Close
  Indian J Med Microbiol
 

Figure 1: Hematoxylin-eosin staining images of SPC212 cancer cells treated with atranorin at different concentrations. The control group (A) and the group treated with 3 μΜ of atranorin (B) are similar in terms of cell morphology. The cells in both groups have normal morphology (thick arrow). Atranorin at 160 (C), 200 (D), 250 (E) and 300 (F) μΜ disrupts cell morphology in a dose dependent manner. Cells shrink in volume and their nuclei are condensed (thin arrow). All pictures are taken at 40* magnification. Scale bars are 50 μm in all figures.

Figure 1: Hematoxylin-eosin staining images of SPC212 cancer cells treated with atranorin at different concentrations. The control group (A) and the group treated with 3 μΜ of atranorin (B) are similar in terms of cell morphology. The cells in both groups have normal morphology (thick arrow). Atranorin at 160 (C), 200 (D), 250 (E) and 300 (F) μΜ disrupts cell morphology in a dose dependent manner. Cells shrink in volume and their nuclei are condensed (thin arrow). All pictures are taken at 40* magnification. Scale bars are 50 μm in all figures.